BOSENTAN CH bosentan (as monohydrate) 62.5 mg film-coated tablet bottle

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

bosentan monohydrate, Quantity: 64.541 mg

Disponible des:

Amneal Pharma Australia Pty Ltd

Designació comuna internacional (DCI):

bosentan monohydrate

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: sodium starch glycollate type A; maize starch; povidone; glycerol dibehenate; magnesium stearate; pregelatinised maize starch; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow; iron oxide red; ethylcellulose

Vía de administración:

Oral

Unidades en paquete:

60

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

for the treatment of,? idiopathic pulmonary arterial hypertension,? familial pulmonary arterial hypertension,? pulmonary arterial hypertension associated with scleroderma or,? pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including Eisenmenger?s physiology,in patients with WHO functional Class II, III or IV symptoms

Resumen del producto:

Visual Identification: Orange, round, biconvex, film coated tablets, debossed with AN on one side and 873 on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Estat d'Autorització:

Licence status A

Data d'autorització:

2017-08-22